Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston
boston blog main
deals
life sciences
national blog main
san francisco blog main
2
×
akouos
astellas pharmaceuticals
azacitidine
beta-thalassemia
boston top stories
california institute for biomedical research
clinical trials
dacogen
decibel therapeutics
decitabine
dna
epigenetics
epizyme
farydak
fda
flagship pioneering
frequency therapeutics
fulcrum therapeutics
harvard university
hearing loss
insulated genomic domains
investing
jeffrey karp
kaleido biosciences
mahesh karande
multiple sclerosis
national top stories
new york blog main
new york top stories
omega therapeutics
panobinostat
perceptive life sciences
regenerative medicine
What
developing
2
×
medicines
therapeutics
2
×
affects
aims
americans
approach
approved
based
biotech
called
date
debuts
drug
drugs
epigenetic
epigenetics
fda
field
flagship’s
frequency
hearing
ipo
loss
meds
millions
morning
new
omega
plans
regenerative
research
startup
step
touting
treat
Language
unset
Current search:
biotech
×
developing
×
" san francisco blog main "
×
therapeutics
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
